SCHEMBL3842262

SCHEMBL3842262

Ic1cncc(N2CCNCC2)c1

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 10/20 0.64
CHRNA4 P43681 10/20 0.64
CHRNA1 P02708 1/20 0.57
CHRNA7 P36544 1/20 0.57
ADRB2 P07550 1/20 0.48
NCF1 P14598 1/20 0.48
PLD1 Q13393 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656901 0.93 CHRNB2 (0.68) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL12205345 0.86 CHRNB2 (0.75) CHRNB2CHRNA4CHRNA1CHRNA7ADRB2
SCHEMBL6094605 0.79 CHRNB2 (0.78) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL23458773 0.78 CHRNB2 (0.69) CHRNB2CHRNA4CHRNA1CHRNA7ADRB2
SCHEMBL3067811 0.78 CHRNB2 (0.81) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL5655329 0.78 CHRNB2 (0.76) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL5656491 0.78 CHRNB2 (0.76) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL11359435 0.78 CHRNB2 (0.64) CHRNB2CHRNA4CHRNA1CHRNA7
SCHEMBL17884952 0.78 CHRNB2 (0.64) CHRNB2CHRNA4CHRNA1CHRNA7ADRB2
SCHEMBL30609720 0.78 CHRNB2 (0.64) CHRNB2CHRNA4CHRNA1CHRNA7ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763351-A4 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORP (US) 2009-08-12 EP disclosed
EP-1763351-A2 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS Incyte Corporation (US) 2007-03-21 EP disclosed
WO-2006004684-A2 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS INCYTE CORPORATION (US) 2006-01-12 WO disclosed